Hopp til innhold
NHI.no
Annonse

Svangerskapsforgiftning (preeklampsi): Forløp

Innhold i artikkelen

Sykdomsforløpet er vanskelig å forutsi, og tilstanden kan i noen tilfeller forverre seg raskt. Hyppige kontroller er derfor viktig.

Blodtrykket normaliserer seg vanligvis allerede noen timer etter fødselen, men det kan være forhøyet i opptil fire uker.

Annonse

I de fleste tilfeller forløper en svangerskapsforgiftning ukomplisert, men det er økt risiko for redusert fostervekst og for tidlig fødsel. De sjeldne tilstandene HELLP og eklampsi er mer alvorlige komplikasjoner som krever intensivbehandling i sykehus. Ved disse tilstandene er det økt risiko for dødelig utgang for mor og barn.

Vil du vite mer

Dette dokumentet er basert på det profesjonelle dokumentet Preeklampsi og hypertensive svangerskapskomplikasjoner . Referanselisten for dette dokumentet vises nedenfor

  1. Staff A, Kvie A, Langesæter E et al. Hypertensive svangerskapskomplikasjoner og eklampsi. Veileder i fødselshjelp 2020. www.legeforeningen.no
  2. Mol BW, Roberts CT, Thangaratinam S, et al. Pre-eclampsia. Lancet 2016. Mar 5;387(10022):999-1011. pmid:26342729 PubMed
  3. Årstabeller for medisinsk fødselsregister 2019. Fødsler i Norge. Folkehelseinstituttet 2020. Siden besøkt 13.08.2020 statistikkbank.fhi.no
  4. Harmon QE, Huang L, Umbach DM, et al. Risk of fetal death with preeclampsia. Obstet Gynecol 2015; 125: 628-35. PMID: 25730226 PubMed
  5. Yang Y, Le Ray I, Zhu J, et al. Preeclampsia Prevalence, Risk Factors, and Pregnancy Outcomes in Sweden and China. JAMA Netw Open 2021; 4: e218401. doi:10.1001/jamanetworkopen.2021.8401 DOI
  6. Sibai BM, Lockwood CJ. HELLP syndrome. UpToDate, last updated Aug 2019. www.uptodate.com
  7. Burton GJ, Redman CW, Roberts JM, Moffett A. Pre-eclampsia: pathophysiology and clinical implications. BMJ. 2019 Jul 15;366:l2381. PMID: 31307997.
  8. Armaly Z, Jadaon JE, Jabbour A, Abassi ZA. Preeclampsia: Novel Mechanisms and Potential Therapeutic Approaches. Front Physiol 2018; 9: 973. pmid:30090069 PubMed
  9. McGinnis R, Steinthorsdottir V, Williams NO, et al. Variants in the fetal genome near FLT1 are associated with risk of preeclampsia. Nat Genet 2017. pmid:28628106 PubMed
  10. Milne F, Redman C, Walker J, et al. Assessing the onset of pre-eclampsia in the hospital day unit: summary of the pre-eclampsia guideline (PRECOG II). BMJ 2009; 339: b3129. pmid: 19740933 PubMed
  11. Chappell LC, Cluver CA, Kingdom J, Tong S. Pre-eclampsia. Seminar. Lancet 2021. doi:10.1016/S0140-6736(20)32335-7 DOI
  12. Rana S1, Powe CE, Salahuddin S et al. Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation 2012; 125: 911-9. pmid:22261192 PubMed
  13. Helsedirektoratet. Nasjonal faglig retningslinje for svangerskapsomsorgen. Oslo, 2018 helsedirektoratet.no
  14. Storgaard M, Loft A, Bergh C et al. Obstetric and neonatal complications in pregnancies conceived after oocyte donation: a systematic review and meta-analysis. BJOG. 2017 Mar;124(4):561-572. Epub 2016 Sep 5. PMID: 27592694.
  15. Bartsch E, Medcalf KE, Park AL, et al. Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies. BMJ 2016; 353: i1753. pmid: 27094586 PubMed
  16. NICE guidelines. Hypertension in pregnancy: diagnosis and management. NICE guidelines NG133. Pub: Jun 2019. Siden besøkt: 17.10.19 www.nice.org.uk
  17. The American College of Obstetricians and Gynecologists' Committee on Practice Bulletins. ACOG Practice Bulletin No. 202: Gestational Hypertension and Preeclampsia. Obstet Gynecol 2019; 133: e1-e25. pmid:30575675 PubMed
  18. Côté A-M, Brown MA, Lam E, et al. Diagnostic accuracy of urinary spot protein:creatinin ratio for proteinuria in hypertensive pregnant women: systematic review. BMJ 2008; 336: 1003-6. PubMed
  19. Eastwood KA, Patterson C, Hunter AJ et al. Evaluation of the predictive value of placental vascularisation indices derived from 3-dimensional power Doppler whole placental volume scanning for prediction of pre-eclampsia: a systematic review and meta-analysis. Placenta 2017; 51: 89-97. pmid:28089506 PubMed
  20. Saffer C, Olson G, Boggess KA et al. Determination of placental growth factor (PlGF) levels in healthy pregnant women without signs or symptoms of preeclampsia. Pregnancy Hypertens 2013; 3: 124-32. pmid:26105949 PubMed
  21. Duhig KE, Myers J, Seed PT, et al. Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial. Lancet 2019. pmid:30948284 PubMed
  22. Nielsen LH, Sundtoft I, Vestgaard MJ et al. Hypertension og præeklampsi. Danske Selskab for Obstetrik og Gynækologi. Obstetrisk Guideline 2018. www.dsog.dk
  23. Bramham K, Parnell B, Nelson-Piercy C, et al. Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis. BMJ. 2014 ;348:g2301. pmid: 24735917 PubMed
  24. Magro-Malosso ER, Saccone G, Di Tommaso M et al. Exercise during pregnancy and risk of gestational hypertensive disorders: a systematic review and meta-analysis. Acta Obstet Gynecol Scand 2017; 96: 921-31. pmid:28401531 PubMed
  25. Meher S, Duley L. Rest during pregnancy for preventing pre-eclampsia and its complications in women with normal blood pressure. Cochrane Database of Systematic Reviews 2006, Issue 2. Art. No.: CD005939 Cochrane (DOI)
  26. Meher S, Abalos E, Carroli G. Bed rest with or without hospitalisation for hypertension during pregnancy. Cochrane Database of Systematic Reviews 2005, Issue 4. Art. No.: CD003514.pub2 Cochrane (DOI)
  27. Palmer KT, Bonzini M, Harris EC et al. Work activities and risk of prematurity, low birth weight and pre-eclampsia: an updated review with meta-analysis. Occup Environ Med 2013; 70: 213-22. pmid:23343859 PubMed
  28. Middleton P, Gomersall JC, Gould JF, Shepherd E, Olsen SF, Makrides M. Omega‐3 fatty acid addition during pregnancy. Cochrane Database of Systematic Reviews 2018, Issue 11. Art. No.: CD003402. DOI: 10.1002/14651858.CD003402.pub3. DOI
  29. Bezerra Maia E Holanda Moura S, Marques Lopes L, Murthi P et al. Prevention of preeclampsia. J Pregnancy 2012; epub: 435090. pmid:23316362 PubMed
  30. McCance DR, Holmes VA, Maresh MJA, et al. Vitamins C and E for prevention of pre-eclampsia in women with type 1 diabetes (DAPIT): a randomised placebo-controlled trial. Lancet 2010; 376: 259-66. PubMed
  31. Abalos E, Duley L, Steyn DW, Gialdini C. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database of Systematic Reviews 2018, Issue 10. Art. No.: CD002252. DOI: 10.1002/14651858.CD002252.pub4. DOI
  32. Duley L, Henderson-Smart DJ, Meher S. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database of Systematic Reviews 2013, Issue 7. Art. No.: CD001449. DOI: 10.1002/14651858.CD001449.pub3 DOI
  33. Berhan Y, Berhan A. Should magnesium sulfate be administered to women with mild pre-eclampsia? A systematic review of published reports on eclampsia. J Obstet Gynaecol Res. 2015 Jun;41(6):831-42. pmid: 25833188 PubMed
  34. Duley L, Gülmezoglu AM, Henderson‐Smart DJ, Chou D. Magnesium sulphate and other anticonvulsants for women with pre‐eclampsia. Cochrane Database of Systematic Reviews 2010, Issue 11. Art. No.: CD000025. DOI: 10.1002/14651858.CD000025.pub2. The Cochrane Library
  35. Churchill D, Duley L, Thornton JG, Moussa M, Ali HSM, Walker KF. Interventionist versus expectant care for severe pre-eclampsia between 24 and 34 weeks' gestation. Cochrane Database of Systematic Reviews 2018, Issue 10. Art. No.: CD003106. DOI: 10.1002/14651858.CD003106.pub3 DOI
  36. Chappell LC, Brocklehurst P, Green ME et al. PHOENIX Study Group. Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial. Lancet. 2019 Sep 28;394(10204):1181-1190. Epub 2019 Aug 28. PMID: 31472930 PubMed
  37. Cluver C, Novikova N, Koopmans CM, West HM. Planned early delivery versus expectant management for hypertensive disorders from 34 weeks gestation to term. Cochrane Database of Systematic Reviews 2017, Issue 1. Art. No.: CD009273. DOI: 10.1002/14651858.CD009273.pub2. DOI
  38. Koopmans CM, Bijlenga D, Groen H, et al. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' getsation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet 2009; 374: 979-88. PubMed
  39. Amorim MMR, Souza ASR, Katz L. Planned caesarean section versus planned vaginal birth for severe pre‐eclampsia. Cochrane Database of Systematic Reviews 2017, Issue 10. Art. No.: CD009430. DOI: 10.1002/14651858.CD009430.pub2. DOI
  40. Rolnik DL, Wright D, Poon LC, et al. Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia. N Engl J Med 2017. PMID: 28657417 PubMed
  41. Henderson JT, Whitlock EP, O'Connor E, et al. Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: A systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med 2014; 160: 695-703. pmid: 24711050 PubMed
  42. Duley L, Meher S, Hunter KE, Seidler AL, Askie LM. Antiplatelet agents for preventing pre‐eclampsia and its complications. Cochrane Database of Systematic Reviews 2019, Issue 10. Art. No.: CD004659. DOI: 10.1002/14651858.CD004659.pub3. The Cochrane Library
  43. Hofmeyr GJ, Manyame S, Medley N, Williams MJ. Calcium supplementation commencing before or early in pregnancy, for preventing hypertensive disorders of pregnancy. Cochrane Database of Systematic Reviews 2019, Issue 9. Art. No.: CD011192. DOI: 10.1002/14651858.CD011192.pub3. The Cochrane Library
  44. Rumbold A, Ota E, Hori H, Miyazaki C, Crowther CA. Vitamin E supplementation in pregnancy. Cochrane Database of Systematic Reviews 2015, Issue 9. Art. No.: CD004069. DOI: 10.1002/14651858.CD004069.pub3. The Cochrane Library
  45. Rumbold A, Ota E, Nagata C, Shahrook S, Crowther CA. Vitamin C supplementation in pregnancy. Cochrane Database of Systematic Reviews 2015, Issue 9. Art. No.: CD004072. DOI: 10.1002/14651858.CD004072.pub3. The Cochrane Library
  46. Poon LC, Shennan A, Hyett JA et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention. Int J Gynaecol Obstet 2019; 145: 1-33. pmid:31111484 PubMed
  47. Ødegaard RA, Vatten LJ, Nilsen ST, Salvesen KÅ, Austgulen R. Preeclampsia and fetal growth. Obstet Gynecol 2000; 96: 950-5. PubMed
  48. Skjaerven R, Wilcox AJ, Klungsøyr K, et al. Cardiovascular mortality after pre-eclampsia in one child mothers: prospective, population based cohort study. BMJ 2012; 345: e7677. pmid: 23186909 PubMed
  49. Brown MC, Best KE, Pearce MS et al. Cardiovascular disease risk in women with pre‐eclampsia: Systematic review and meta‐analysis. Eur J Epidemiol 2013; 28: 1-19. pmid:23397514 PubMed
  50. Kessous R, Shoham-Vardi I, Pariente G et al. Long-term maternal atherosclerotic morbidity in women with pre-eclampsia. Heart 2015; 101: 442-6. pmid:25564558 PubMed
  51. Stuart JJ, Tanz LJ, Missmer SA et al. Hypertensive Disorders of Pregnancy and Maternal Cardiovascular Disease Risk Factor Development: An Observational Cohort Study. Ann Intern Med 2018; 169: 224-32. pmid:29971437 PubMed
Annonse
Annonse